Potential treatment for fatal lung diseases

Researchers have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal. Pulmonary fibrosis occurs when lung tissue becomes scarred. Pulmonary hypertension involves an increase of blood pressure in the arteries of the lung that can lead to heart failure.